Why pharma stocks Cipla, Zydus, Biocon will remain in focus for different reasons on Friday
Published on: Jan. 16, 2026, 7:21 a.m. | Source: The Hindu Business Line
Pharma stocks rise as Cipla faces supply issues, Zydus gains FDA approval, and Biocon secures funding through a QIP.
